JustInvest LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,470 shares of the healthcare conglomerate’s stock after purchasing an additional 3,836 shares during the period. UnitedHealth Group makes up about 0.9% of JustInvest LLC’s holdings, making the stock its 14th largest holding. JustInvest LLC’s holdings in UnitedHealth Group were worth $5,756,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Accel Wealth Management acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $26,000. Atlas Private Wealth Advisors grew its position in shares of UnitedHealth Group by 46.2% during the first quarter. Atlas Private Wealth Advisors now owns 95 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 30 shares in the last quarter. Sage Private Wealth Group LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $36,000. IronBridge Private Wealth LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $37,000. Finally, Costello Asset Management INC lifted its position in shares of UnitedHealth Group by 500.0% during the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock worth $42,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
Several research firms have recently issued reports on UNH. Bank of America reaffirmed a “buy” rating and set a $415.00 price objective on shares of UnitedHealth Group in a research report on Thursday, January 21st. Truist Securities boosted their price objective on shares of UnitedHealth Group from $420.00 to $450.00 and gave the stock a “buy” rating in a research report on Tuesday, April 20th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $375.00 to $440.00 and gave the stock an “outperform” rating in a research note on Thursday, April 22nd. Mizuho raised their price objective on UnitedHealth Group from $380.00 to $394.00 and gave the stock a “buy” rating in a report on Thursday, April 15th. Finally, Barclays upped their target price on UnitedHealth Group from $405.00 to $435.00 and gave the company an “overweight” rating in a research report on Thursday, April 22nd. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $409.61.
Shares of UNH stock traded up $1.10 during trading hours on Tuesday, reaching $407.00. 35,547 shares of the company’s stock were exchanged, compared to its average volume of 3,262,127. UnitedHealth Group Incorporated has a 1 year low of $273.71 and a 1 year high of $406.77. The company has a market cap of $384.16 billion, a P/E ratio of 23.31, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. The company’s 50 day moving average is $378.48 and its two-hundred day moving average is $349.25. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, beating the consensus estimate of $4.38 by $0.93. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm had revenue of $70.20 billion during the quarter, compared to the consensus estimate of $69.13 billion. During the same period last year, the business posted $3.72 EPS. UnitedHealth Group’s quarterly revenue was up 9.0% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 16.75 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Recommended Story: What are the risks of holding treasury bonds?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.